Clinical Trials Logo

Mild to Moderate Acne clinical trials

View clinical trials related to Mild to Moderate Acne.

Filter by:
  • None
  • Page 1

NCT ID: NCT06420804 Completed - Clinical trials for Mild to Moderate Acne

Evaluation of the Safety and Efficacy of an Acne Treatment Device

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

A 50-patient study in which 400 microamps of direct current was applied 3 days per week. All tolerability, safety and efficacy endpoints were met.

NCT ID: NCT05613660 Completed - Healthy Clinical Trials

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

Start date: January 11, 2023
Phase: N/A
Study type: Interventional

A proof of science clinical study with randomized, four-arm, comparative, single-blind, within the arm - Dose-Response Study to evaluate the safety and efficacy of different collagen peptide-containing test treatments in adult human subjects. The dose-response will be evaluated for the effectiveness of each test treatment in three different dosages that is 2.5 g Versus 5 g Versus 10 g. 22 subjects will be enrolled per dose per test treatment to complete 20 subjects per dose per test treatment.

NCT ID: NCT01257555 Completed - Clinical trials for Mild to Moderate Acne

Evaluation of a Photopneumatic System for the Treatment of Acne

Start date: December 2010
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate the safety and efficacy of a photopneumatic therapy for the treatment of acne and concomitant symptoms associated with the disease, including erythema.

NCT ID: NCT00988026 Recruiting - Clinical trials for Mild to Moderate Acne

Safety and Efficacy Comparison of Minocycline Microgranules Versus Lymecycline in the Treatment of Mild to Moderate Acne

MXMIN-001
Start date: June 2009
Phase: Phase 4
Study type: Interventional

This is a clinical trial to compare the benefits and possible adverse events of two antibiotic treatments for mild to moderate acne. It is expected that minocycline microgranules will be more effective than lymecycline with a better adverse events profile.